INNATE PHARMA (EPA:IPH) | WebDisclosure

PRESS RELEASE

published on 09/02/2025 at 07:00, 9 months 24 days ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Innate Pharma releases the total number of shares (92,185,473 ordinary shares, 6,419 Preferred Shares 2016, 7,581 Preferred Shares 2017) and voting rights (92,962,943 theoretical, 92,944,368 exercisable) as of September 1, 2025 in compliance with regulations

Voting Rights Shares Stock Market Regulations Innate Pharma
PRESS RELEASE

published on 09/02/2025 at 07:00, 9 months 24 days ago

Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Innate Pharma publie le nombre d'actions et de droits de vote au 1er septembre 2025 selon les régulations AMF. Détails du capital social et des droits de vote

Droits De Vote Biotechnologie Actions AMF Innate Pharma
BRIEF

published on 08/04/2025 at 07:05, 10 months 22 days ago

New number of shares and voting rights for Innate Pharma

AMF Financial Update Shares And Voting Rights Commercial Code Innate Pharma
BRIEF

published on 08/04/2025 at 07:05, 10 months 22 days ago

Nouveau nombre d'actions et de droits de vote pour Innate Pharma

Code De Commerce AMF Innate Pharma Actions Et Droits De Vote Actualisation Financière
PRESS RELEASE

published on 08/04/2025 at 07:00, 10 months 22 days ago

Inside Information / Other news releases
Innate Pharma discloses total shares outstanding and voting rights as of August 1, 2025. The company is a global biotech developing immunotherapies for cancer patients

Voting Rights Biotechnology Immunotherapy Innate Pharma Shares Outstanding
PRESS RELEASE

published on 08/04/2025 at 07:00, 10 months 22 days ago

Informations privilégiées / Autres communiqués
Innate Pharma publie son nouveau nombre d'actions et de droits de vote au 1er août 2025 selon les réglementations de l'AMF. Détails ci-dessous

Nombre D'actions Droits De Vote AMF Innate Pharma Biotechnologies
BRIEF

published on 07/04/2025 at 07:05, 11 months 22 days ago

Innate Pharma annonce une mise à jour de ses actions et de ses droits de vote

Euronext Actions Nasdaq Droit De Vote Innate Pharma
BRIEF

published on 07/04/2025 at 07:05, 11 months 22 days ago

Innate Pharma Announces Share and Voting Rights Update

Voting Rights Shares Euronext Nasdaq Innate Pharma
PRESS RELEASE

published on 07/04/2025 at 07:00, 11 months 22 days ago

Inside Information / Other news releases
Innate Pharma discloses number of shares and voting rights as of July 3, 2025, in accordance with French regulations. Total shares: 92,183,523. Total voting rights: 92,962,943 (theoretical) and 92,944,368 (exercisable)

Voting Rights Shares French Regulations Financial Disclosure Innate Pharma
BRIEF

published on 06/17/2025 at 07:05, 1 year ago

Innate Pharma to Participate in Key Investor Conferences

Biotechnology Investor Conferences Healthcare Immunotherapy Innate Pharma

Published on 06/26/2026 at 22:15, 30 minutes ago

Revive Therapeutics Announces Proposed Private Placement
Published on 06/26/2026 at 15:05, 7 hours 40 minutes ago

Vox Royalty Sells I-80 Gold Offtake Stream
Published on 06/26/2026 at 14:05, 8 hours 40 minutes ago

SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 8 hours 45 minutes ago

Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 9 hours 45 minutes ago

Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana

View all ACCESSWIRE

Published on 06/26/2026 at 19:50, 2 hours 55 minutes ago

Name Change Completed for C Capital's Swiss Listed Entity, Ticker Symbol CCAP Goes Live
Published on 06/26/2026 at 19:10, 3 hours 35 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/26/2026 at 18:04, 4 hours 41 minutes ago

Turkiye Garanti Bankasi A.S.: Bond, subordinated debts, that can be included in the equity calculation debt instrument issuance CMB Application
Published on 06/26/2026 at 18:00, 4 hours 45 minutes ago

PSP Swiss Property has sold the Richtipark in Wallisellen. The EBITDA guidance for the 2026 financial year has been increased.
Published on 06/26/2026 at 18:00, 4 hours 45 minutes ago

VALBIOTIS SA: Valbiotis announces the success of its capital increase of €10.2M

View all EQS

Published on 06/26/2026 at 17:45, 5 hours ago

Combined General Meeting, June 25, 2026
Published on 06/26/2026 at 17:45, 5 hours ago

Assemblée générale mixte du 25 juin 2026
Published on 06/26/2026 at 17:45, 5 hours ago

Descriptif du programme de rachat d'actions
Published on 06/26/2026 at 14:44, 8 hours 1 minute ago

Safran information
Published on 06/26/2026 at 14:44, 8 hours 1 minute ago

Information Safran

View all LES ECHOS COMFI WIRE

News